18 results
8-K
EX-99.1
ABSI
Absci Corp
2 Nov 22
Absci Welcomes Meta Senior Executive to Board of Directors
4:06pm
and biotech industries, now more than ever, Dan’s experience and insights will be invaluable in our mission to create better biologics, faster.”
Since
8-K
EX-99.1
ABSI
Absci Corp
6 Jun 23
Departure of Directors or Certain Officers
4:08pm
most about Absci's mission is the prospect of accelerating the development of breakthrough therapies, together with pharma and biotech companies
8-K
EX-99.1
ABSI
Absci Corp
14 Aug 23
Absci Reports Business Updates and Second Quarter 2023 Financial and Operating Results
8:13am
toward our mission of creating better biologics for patients, faster."
Recent Highlights
Entered into partnership with a Google Ventures-backed
8-K
EX-99.1
ABSI
Absci Corp
15 May 23
Absci Reports Business Updates and First Quarter 2023 Financial and Operating Results
4:08pm
strategic portfolio across a range of therapeutic areas — and achieve our mission of creating better biologics for patients, faster."
Recent
PRE 14A
ABSI
Absci Corp
11 Apr 23
Preliminary proxy
5:49pm
, we are dedicated to a bold mission of creating better biologics for patients, faster. 2022 was an important year of progress and evolution for us as we … truly believe in the transformative technology we have built, the people that make our organization great, and the powerful potential of our mission
424B4
cj1g3kvte
23 Jul 21
Prospectus supplement with pricing info
4:49pm
S-1/A
ij7 o12uxfvmcaw808u8
8 Jul 21
IPO registration (amended)
5:04pm
S-1
84a9jd2q
30 Jun 21
IPO registration
3:20pm
DRS/A
8zsaale5k6qoue1pgxj
16 Jun 21
Draft registration statement (amended)
12:00am
DRS
bgs25wddxianzqn
6 May 21
Draft registration statement
12:00am
10-K
fflwppdiu ybz3e2zsj
22 Mar 22
Annual report
5:20pm
ARS
zhfb7r65aab
28 Apr 23
Annual report to shareholders
12:00am
ARS
5j9i2cvg66
23 Apr 24
Annual report to shareholders
4:10pm
- Prev
- 1
- Next